BRIEF published on 05/16/2024 at 14:35, 1 year 6 months ago GreenBank Capital Announces Private Placement and Debt Conversion Plans Private Placement Equity Offering Financial Restructuring GreenBank Capital Debt Conversion
PRESS RELEASE published on 05/16/2024 at 14:30, 1 year 6 months ago Private Placement GreenBank Capital announces $1.25M private placement offering and debt settlement to eliminate $450,000 in debt, with the first tranche expected to close by 30th May 2024 Debt Settlement Private Placement Offering Investment Strategy Restructuring GreenBank Capital
BRIEF published on 05/14/2024 at 14:06, 1 year 6 months ago GreenBank Capital Inc. Announces Strategic Financial and Personnel Changes Stock Options CFO Appointment Executive Changes Corporate Finance Cost Reduction
PRESS RELEASE published on 05/14/2024 at 14:01, 1 year 6 months ago Reduction of Directors' Compensation, Introduction of New Stock Option Plan, and Appointment of New CFO GreenBank Capital appoints new CFO, reduces directors' pay, and introduces incentive stock option plan to cut costs and enhance growth opportunities CFO Appointment Financial Sector Stock Option Plan GreenBank Capital Directors' Compensation
BRIEF published on 05/02/2024 at 18:30, 1 year 7 months ago GreenBank Capital Announces Strong Quarter with Active Strategic Developments Revenue Generation Strategic Investments Financial Update GreenBank Capital Suni Iron Project
PRESS RELEASE published on 05/02/2024 at 18:25, 1 year 7 months ago Quarterly update GreenBank Capital updates shareholders on CTO revocation, income generation, Staminier and Suni Iron Project progress. GreenBank focuses on strategic investments to drive growth and shareholder value GreenBank Capital Suni Iron Project CTO Revocation Income Generation Staminier Update
BRIEF published on 05/01/2024 at 17:05, 1 year 7 months ago Greenbank Capital Inc. Secures Revocation of Cease Trade Order Canadian Securities Exchange Cease Trade Order Financial Compliance Securities Regulation GreenBank Capital
PRESS RELEASE published on 05/01/2024 at 17:00, 1 year 7 months ago Greenbank Capital Inc. Announces Revocation of Failure-to-File Cease Trade Order Greenbank Capital Inc. announces the revocation of the failure-to-file cease trade order by the Ontario Securities Commission, ensuring compliance with financial reporting obligations Compliance Financial Reporting Ontario Securities Commission Greenbank Capital Inc. Revocation Order
BRIEF published on 04/02/2024 at 00:00, 1 year 8 months ago GreenBank Capital Faces Challenges with Staminier Loan, Lawsuit, and Trading Halt Cease Trade Order Lawsuit GreenBank Capital Staminier Limited Future Fund
PRESS RELEASE published on 04/01/2024 at 23:55, 1 year 8 months ago Update on Staminier, Lawsuit and CTO Staminier Future Fund loan extension request rejected by British Business Bank, leading to potential insolvency. GreenBank faces lawsuit and cease trade order amidst uncertainties about sale of The Substantia Group Cease Trade Order Lawsuit Future Fund Staminier GreenBank
Published on 12/05/2025 at 02:35, 2 hours 52 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 27 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 22 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 27 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 57 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 37 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 2 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 12 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 17 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 27 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 42 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 43 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 26 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
